SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-20-119044
Filing Date
2020-04-24
Accepted
2020-04-24 16:05:12
Documents
4
Period of Report
2020-05-27
Effectiveness Date
2020-04-24

Document Format Files

Seq Description Document Type Size
1 DEF 14A d922121ddef14a.htm DEF 14A 442473
2 GRAPHIC g922121g56r37.jpg GRAPHIC 31680
3 GRAPHIC g922121pc1.jpg GRAPHIC 160751
4 GRAPHIC g922121pc2.jpg GRAPHIC 125388
  Complete submission text file 0001193125-20-119044.txt   881204
Mailing Address 101 MONTGOMERY STREET, SUITE 2550 SAN FRANCISCO CA 94104
Business Address 101 MONTGOMERY STREET, SUITE 2550 SAN FRANCISCO CA 94104 650-391-9740
Eidos Therapeutics, Inc. (Filer) CIK: 0001731831 (see all company filings)

IRS No.: 463733671 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38533 | Film No.: 20814960
SIC: 2834 Pharmaceutical Preparations